John G. Lemkey, Officer, Chief Financial Officer, Chief Operating Officer, Chief Executive Officer at Odonate Therapeutics, Inc. (ODT), bought 132,616 shares at $26.31 ($3.6M) on 2019-06-07, disclosed to the SEC on 2019-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.56 | 6,308 | $174K | 4.8% |
| 2 | $27.56 | 6,308 | $174K | 4.8% |
| 3 | $27.71 | 41,312 | $1.1M | 31.4% |
| 4 | $27.71 | 41,312 | $1.1M | 31.4% |
| 5 | $27.95 | 8,688 | $243K | 6.7% |
| 6 | $27.95 | 8,688 |
| $243K |
| 6.7% |
| 7 | $26.31 | 20,000 | $526K | 14.4% |
| Total | $27.52 avg | 132,616 | $3.6M | 100% |
| Filing → |
| ODT | BUY | 2018-12-26 | $756K | — | Filing → |
| ODT | BUY | 2018-12-18 | $848K | — | Filing → |
| ODT | BUY | 2018-10-25 | $919K | — | Filing → |